Barbara Clendenen

Barbara Clendenen has an extensive work experience spanning over 20 years. Barbara'smost recent role is as the Chief Business Development Officer at Validant, a position they have held since 2022. Prior to that, they served as the Director of Business Development at NDA Group AB from 2017 to 2021. Before that, they were the Director of Business Development at Synowledge LLC from 2016 to 2017. Barbara also held the position of Director of Business Development at Meeting Protocol Worldwide from 2015 to 2016. Barbara has experience as the Director of Sales and National Manager of Business Development at Quorum Review IRB from 2009 to 2015. Previously, they worked as an Account Manager at Bio-Rad Laboratories from 2007 to 2009 and in Large Group Sales at Humana from 2005 to 2007. Barbara began their career as a Life Science Specialist at Thermo Fisher Scientific from 1999 to 2004.

Barbara Clendenen pursued their education in a chronological manner. Barbara embarked on their academic journey by enrolling at the University of Washington from 1987 to 1991. During this period, they earned a Bachelor of Science degree with a focus on Microbiology. Following their undergraduate studies, Barbara pursued a Masters degree in Business Administration at Seattle University. Barbara attended Seattle University from 2001 to 2004, specializing in the field of Business Administration.